3 Predictions for Rocket Lab in 2026

Rocket Lab expects first flight of its next‑generation reusable Neutron rocket in H1 2026, but a qualification test tank rupture has already knocked the stock about 16% lower and could delay the debut; management plans to discuss details at the Q4 2025 earnings call. The company’s smaller Electron vehicle, which has completed 81 launches and deployed nearly 250 satellites, remains the primary revenue driver and cash generator whose launch cadence directly affects margins and funds Neutron development; the stock’s beta of 2.18 signals materially higher volatility and sensitivity to launch news and any SpaceX IPO comparisons.

Analysis

Market structure: A successful Neutron program would make RKLB a clear winner—capturing larger payloads and higher-margin deep-space missions—and expand pricing power vs. small-launch peers. Electron customers (smallsat operators, government rideshares) and composite-tank suppliers benefit from cadence growth, while pure single-vehicle small-launch startups and some incumbents may lose share. Expect implied volatility in options to spike around Neutron milestones and earnings; small-cap credit spreads could widen on negative news, pressuring funding costs for RKLB and peers.

Risk assessment: Tail risks include catastrophic Neutron test failure, a >6‑12 month program delay, or an equity raise that dilutes current holders; any of these could drive >30–50% downside. Near-term (days–weeks) risk centers on the Q4 2025 earnings call and disclosures; short-term (weeks–months) risk is program fixes and certificate timelines; long-term (12–36 months) hinges on Electron cashflow funding Neutron and securing third‑party manifests. Hidden dependency: Electron launch cadence is the de‑risking cash source—slower manifests materially raise burn and dilute runway.

Trade implications: For investors who want exposure, size RKLB as a tactical 2–3% position with explicit hedges rather than unhedged beta exposure; use 3–6 month 25% OTM puts or a 60–90 day ATM straddle into the earnings/Neutron-update window to monetize elevated IV. Pair trades (long RKLB, short a diversified space/small‑cap ETF like ARKX) can isolate idiosyncratic Neutron upside while neutralizing sector shocks. Rotate out of small-cap industrials into higher-quality aerospace primes if liquidity tightens.

Contrarian angles: The market may be over‑penalizing RKLB for a single tank rupture—Electron revenue of ~80+ launches (histor cadence) provides predictable near‑term cash; a successful static‑fire + three anchor Neutron customers would likely rerate shares >50% over 12 months. Conversely, a successful Neutron could trigger a frothy re‑rating and follow‑on dilution; set mechanical add/trim rules (buy on -20%, add on successful milestones, trim on +40%).

Key Decisions for Investors

• Establish a 2–3% long position in Rocket Lab (RKLB) with a 12–24 month horizon; scale in if shares fall another 20% and trim/lock profits when position is +40% or immediately after a successful Neutron first launch.
• Hedge the equity position by buying 3–6 month puts ~25% OTM sized to cap portfolio downside to ~50% of the RKLB notional, OR purchase a 60–90 day ATM straddle ahead of the Q4 2025 earnings/Neutron update (expected within ~30 days) to capture event-driven IV — prefer puts if premium exceeds ~10% of position value.
• Execute a pair trade: long RKLB (1–2% of portfolio) vs short equal-dollar exposure to a space/small-cap ETF such as ARKX for 6–12 months to isolate idiosyncratic Neutron upside while hedging sector volatility; rebalance on major milestones.
• Set hard triggers: if RKLB announces equity raising or Neutron delay >60 days beyond H1 2026, reduce RKLB exposure to zero within 5 trading days; if RKLB announces ≥3 commercial/government Neutron commitments within 6 months, increase allocation to 4–5%.